Indicated for: psoriasis
Route of administration: cutaneous
Substance: calcipotriol + betamethasone (immunomodulator + glucocorticoid)
ATC: D05AX52 (Dermatologicals | Antipsoriatics for topical use | Other antipsoriatics for topical use)
Use caution if you have glaucoma or increased eye pressure.
Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.
Avoid live vaccines during treatment if contraindicated.
This medicine may increase blood sugar.
This medicine may increase the risk of infections.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Do not stop treatment abruptly without medical advice.
Calcipotriol and betamethasone are used together for the treatment of plaque psoriasis, a chronic skin condition characterized by red patches covered with whitish scales. This combination reduces inflammation, itching, and slows down the excessive growth of skin cells.
Calcipotriol is a vitamin D analog that helps normalize the cell regeneration process, while betamethasone is a potent corticosteroid that reduces inflammation and suppresses local immune reactions.
The treatment is applied topically, usually in the form of an ointment or gel, and is intended for short-term use to avoid corticosteroid-related side effects. It is important to avoid application on the face, skin folds, or areas with thin skin.
Side effects may include local irritation, burning sensation, or itching. Long-term use can lead to skin thinning or other corticosteroid-related complications.
Price
Copayment
Patient
41.59 RON
20.80 RON
20.80 RON